To make sure the questions relate to COVID-19 and not the Guide 100 or other Health Canada issues on COVID-19 questions already addressed by the COVID-19 guide, Health Canada would like us to collect questions in advance. We have not received any questions to date, so...
Read the Spring N2 newsletter available in both English and French.
Enhancing Canada’s Research Capability & Capacity
years of service
Our membership has allowed us to learn from successes in other provinces, implement new ideas, keep abreast of new developments in the Canadian clinical trials landscape, and network with other clinical research groups faced with similar challenges and opportunities.
It is well worth attending the two-day Annual General Meetings and with each successive AGM, you can see and hear how N2 is growing by leaps and bounds and likewise the enthusiasm and volunteerism exhibited at the meetings, all of which makes for relevant and informative discussions.
Through their outreach to various stakeholders, N2 partnership definitely gives Canada an edge and helps us, the pharmaceutical industry, to continue to attract and leverage the implementation of clinical trials in Canada; ensuring a high level of quality and compliance.
Being a member of N2 has provided us with the opportunity to develop collaborative working relationships with clinical research organizations across Canada. These networking opportunities have helped us to streamline processes, share and create resources, and learn from other clinical research experts’ experiences.